Cite
The efficacy and safety of intravenous chlorpromazine treatment for sleep disturbance in patients with incurable cancer, with oral administration difficulty: a 1-week, prospective observational study
MLA
Kazuki Uchitani, et al. “The Efficacy and Safety of Intravenous Chlorpromazine Treatment for Sleep Disturbance in Patients with Incurable Cancer, with Oral Administration Difficulty: A 1-Week, Prospective Observational Study.” Annals of Palliative Medicine, vol. 10, no. 8, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5feeecb7904b063e636960e159f2cfc3&authtype=sso&custid=ns315887.
APA
Kazuki Uchitani, Hideaki Hasuo, Hiroko Sakuma, Miyuki Okada, & Ryohei Fujii. (2021). The efficacy and safety of intravenous chlorpromazine treatment for sleep disturbance in patients with incurable cancer, with oral administration difficulty: a 1-week, prospective observational study. Annals of Palliative Medicine, 10(8).
Chicago
Kazuki Uchitani, Hideaki Hasuo, Hiroko Sakuma, Miyuki Okada, and Ryohei Fujii. 2021. “The Efficacy and Safety of Intravenous Chlorpromazine Treatment for Sleep Disturbance in Patients with Incurable Cancer, with Oral Administration Difficulty: A 1-Week, Prospective Observational Study.” Annals of Palliative Medicine 10 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5feeecb7904b063e636960e159f2cfc3&authtype=sso&custid=ns315887.